Valentis Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-01-2025
- Paid Up Capital ₹ 0.10 M
as on 05-01-2025
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -79.67%
(FY 2022)
- Profit -338.43%
(FY 2022)
- Ebitda -338.43%
(FY 2022)
- Net Worth -15.42%
(FY 2022)
- Total Assets -59.28%
(FY 2022)
About Valentis Life Science
The Corporate was formerly known as Vivek Life Science Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vivekbhai Rami and Vatsal Rami serve as directors at the Company.
- CIN/LLPIN
U24239GJ2008PTC052683
- Company No.
052683
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jan 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Valentis Life Science?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivekbhai Rami  | Managing Director | 21-Jan-2008 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vatsal Rami | Director | 04-Apr-2018 | Current |
Financial Performance of Valentis Life Science.
Valentis Life Science Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 79.67% decrease. The company also saw a substantial fall in profitability, with a 338.43% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Valentis Life Science?
In 2020, Valentis Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Universal Skin Impex Private LimitedActive 13 years 5 monthsVivekbhai Rami and Vatsal Rami are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Valentis Life Science?
Unlock and access historical data on people associated with Valentis Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Valentis Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valentis Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
